Acurx Pharmaceuticals Inc.
ACXP | NASDAQ
$1.33
-$0.06 (-4.32%)
At close: Sep 21, 2026, 4:00 PM ET
$1.31
-$0.02 (-1.50%)
Pre-market:
Sep 22, 2026, 7:49 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.25M | -1.68M | -1.58M | -1.99M | -2.25M | -2.15M | -2.78M | -2.82M | -4.12M | -4.38M | -5.11M | -3.11M | -3.45M | -2.9M | -3.26M | -3.54M | -2.62M | -2.67M | -2.63M | -4.64M | -4M | -1.47M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | 319.29K | 375.79K | 339.85K | 410.4K | 443.68K | 538.37K | 466.59K | 1.23M | 1.2M | 1.23M | 833.29K | 806.49K | 899.38K | 812.47K | 824.05K | 716.68K | 949.17K | 760.14K | 3.4M | 2.26M | 327.14K |
Other Working Capital | 301.68K | -37.94K | 25.95K | -228.03K | 205.52K | -397.11K | -53.22K | 211.43K | 62.18K | -14.33K | -310.15K | 188.19K | 1.06M | 70.65K | 952.46K | 537.5K | -86.8K | -155.03K | 366.75K | -1.39M | 1.48M | -316.71K |
Other Non-Cash Items | 281.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -66.5K | 916.77K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 262.69K | -45.84K | 17.74K | -228.03K | 165.31K | -345.98K | -6.98K | 165.19K | 11.05K | 114.83K | -310.15K | 188.19K | 1.06M | 70.65K | 952.46K | 537.5K | -86.8K | -155.03K | 366.75K | -1.39M | 1.48M | -316.71K |
Operating Cash Flow | -1.71M | -1.41M | -1.18M | -1.88M | -1.67M | -2.05M | -2.25M | -2.19M | -2.88M | -3.06M | -4.2M | -2.09M | -1.58M | -1.93M | -1.5M | -2.18M | -1.99M | -1.88M | -1.5M | -2.64M | -329.81K | -547.14K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | -1.04K | 2.48M | n/a | n/a | n/a | n/a | 210.2K | 2.22M | 3.54M | 73 | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 3.11M | 3.11M | 2.83M | 1.72M | 3.09M | 2.99M | 194.55K | 1.59M | 320.21K | 4.51M | 4.62M | n/a | 3.54M | n/a | -1 | 3.7M | n/a | n/a | n/a | n/a | 14.8M | n/a |
Net Cash Flow | 1.4M | 1.7M | 1.65M | -157.33K | 1.42M | 937.17K | -2.06M | -598.29K | -2.56M | 1.45M | 421.86K | -2.09M | 1.97M | -1.93M | -1.5M | 1.52M | -1.99M | -1.88M | -1.5M | -2.64M | 14.47M | -547.14K |
Free Cash Flow | -1.71M | -1.41M | -1.18M | -1.88M | -1.67M | -2.05M | -2.25M | -2.19M | -2.88M | -3.06M | -4.2M | -2.09M | -1.58M | -1.93M | -1.5M | -2.18M | -1.99M | -1.88M | -1.5M | -2.64M | -329.81K | -547.14K |
Adj. Free Cash Flow | -1.71M | -1.73M | -1.56M | -2.22M | -2.08M | -2.5M | -2.79M | -2.66M | -4.11M | -4.26M | -5.42M | -2.93M | -2.38M | -2.83M | -2.31M | -3M | -2.71M | -2.83M | -2.26M | -6.03M | -2.59M | -874.28K |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -1.71M | -1.41M | -1.18M | -1.88M | -1.67M | -2.05M | -2.25M | -2.19M | -2.88M | -3.06M | -4.2M | -2.09M | -1.58M | -1.93M | -1.5M | -2.18M | -1.99M | -1.88M | -1.5M | -2.64M | -329.81K | -547.14K |
Add to Watchlist
Select watchlists to add or remove ACXP